Sponsored by:

Molecular Imaging: Page 321

Naviscan's PEM gets CE Mark
By AuntMinnie.com staff writers
PET developer Naviscan has received the CE Mark for both its high-resolution positron emission mammography (PEM) scanner and PET-guided biopsy accessory.
September 27, 2011
Dilon to distribute SurgicEye products
By AuntMinnie.com staff writers
Breast-specific gamma imaging developer Dilon Diagnostics has become the exclusive distributor of SurgicEye's intraoperative soft-tissue imaging and navigation products in the U.S.
September 27, 2011
NaF-PET proves best for pediatric skeletal imaging
By Wayne Forrest
Skeletal imaging with sodium fluoride (NaF) PET provides "superior imaging" compared to standard nuclear imaging techniques and can help physicians accurately investigate the cause of bone pain in children, according to a paper in the September issue of the American Journal of Roentgenology.
September 27, 2011
2011 09 27 13 46 49 239 Druback Figure1 Thumb
Siemens PET/MRI unit tested for PTSD patients
By AuntMinnie.com staff writers
Siemens Healthcare's Biograph mMR PET/MRI system is being tested at the Uniformed Services University of the Health Sciences' Center for Neuroscience and Regenerative Medicine for diagnosing and treating military service members and civilians suffering from traumatic brain injury and post-traumatic stress disorder (PTSD).
September 26, 2011
ACR to host IT, radiation dose forum
By AuntMinnie.com staff writers
The American College of Radiology (ACR) will hold its first annual ACR Imaging Informatics Summit and Dose Monitoring Forum on November 3 and 4.
September 22, 2011
Report: Bayer to sell molecular imaging unit
By AuntMinnie.com staff writers
German pharmaceutical firm Bayer plans to restructure its diagnostic business by selling its molecular imaging unit, according to a September 16 report in the German issue of the Financial Times.
September 22, 2011
Positron receives disaster area bonds
By AuntMinnie.com staff writers
Molecular imaging developer Positron has been awarded $38 million in disaster area bonds by the Indiana Finance Authority.
September 20, 2011
Peptide therapy reduces tumor size, side effects
By AuntMinnie.com staff writers
Dutch researchers are reporting on a peptide receptor radiolabeled therapy that can decrease both tumor size and the severity of side effects in cancer patients in this month's issue of the Journal of Nuclear Medicine.
September 20, 2011
ACR tweaks rules for SPECT phantoms
By AuntMinnie.com staff writers
After a review of nuclear medicine accreditation program requirements, the American College of Radiology's (ACR) subcommittee on nuclear medicine physics has eliminated the need for sites to submit SPECT phantoms utilizing thallium-201, gallium-67, or indium-111.
September 19, 2011
SPECT/MPI guidelines reduce inappropriate exams
By Wayne Forrest
Appropriateness criteria developed in 2009 by the American College of Cardiology and the American Society of Nuclear Cardiology (ASNC) performed "fairly well" for certain indications, reducing the number of inappropriate imaging exams, according to a study presented at ASNC's annual meeting in Denver last week.
September 18, 2011
Nordion posts Q3 gains, warns of reactor downtime
By AuntMinnie.com staff writers
Strong year-over-year growth from its TheraSphere therapeutic radiopharmaceutical business and cobalt-60 shipments powered Nordion to a 39% increase in revenue in the company's third quarter of fiscal-year 2011.
September 15, 2011
Mirada inks deal with clinical trial firm
By AuntMinnie.com staff writers
Medical imaging software developer Mirada Medical has signed an agreement with clinical trial support firm ABX-CRO that will allow the company to use Mirada's multimodality imaging applications for clinical trials in oncology and the neurosciences.
September 14, 2011
Previous Page
Page 321 of 612
Next Page